“In many European countries, double-reading for mammography is the standard of care, yet this can pose a challenge due to the global shortage of mammography professionals. This can lead to burnout and ultimately, missed cancers,” said Dr. Gräwingholt. “ProFound AI offers a viable and impactful solution. It helps our team find more cancers – and with greater accuracy – demonstrating the real-world value this solution offers as a trustworthy second set of eyes. With this technology, clinicians can feel confident that they are catching cancers earlier, when they may be more easily treated.”
Additional presentations supporting iCAD’s Breast AI Suite to be featured at RSNA.
Ad Statistics
Times Displayed: 2839
Times Visited: 27 Fast-moving cardiac structures have a big impact on imaging. Fujifilm’s SCENARIA View premium performance CT brings solutions to address motion in Coronary CTA while delivering unique dose saving and workflow increasing benefits.
Monday, November 28:
1:30-2:30 pm CST
“Long-term Performance of an Image-based Short-term Risk Model for Breast Cancer”
(Oral presentation - Session Number: M6-SSBR04)
Mikael Eriksson, PhD, Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Solna, Sweden, will present findings from a study that supports iCAD’s first in kind breast cancer risk evaluation tool, ProFound AI® Risk. The study showed ProFound AI Risk has the potential to assess short-term risk for capturing women with estrogen-negative breast cancers in need of supplemental screening and long-term risk for women who could benefit from primary prevention of estrogen-positive breast cancer.
Tuesday, November 29:
3:00-4:00 pm CST
“Using an Artificial Intelligence System to Implement Limited Double Reading in a Single Reader Environment”
(Oral presentation - Session Number: T7-SSBR06)
Robert Nishikawa, PhD, Professor, Department of Radiology, Imaging Research Laboratory at the University of Pittsburgh Center for Artificial Intelligence Innovation in Medical Imaging, will discuss the feasibility of using ProFound AI to triage selected cases for double reading in a single reader environment. The study showed double reading directed by ProFound AI can efficiently reduce the recall rate by 9%, resulting in only 3% more reads by a second radiologist.
3:30-3:45 pm CST
“Leveraging ProFound AI to Enhance Patient Care at Solis Mammography”
(Oral presentation - AI Showcase Open-Air Theater)
Chirag Parghi, MD, Chief Medical Officer, Solis Mammography, the largest independent provider of mammography and breast health services in the United States, will share the company’s experience in deploying ProFound AI across its network of facilities.
During the conference, iCAD will also host a series of “Meet the Experts” sessions throughout the week, as well as a “Cocktails and Conversations” event on November 28 featuring renowned leaders in breast imaging AI who will be available to share their experience with iCAD’s Breast AI Suite.
